JOHN WILEY & SONS LTD

• 

  Publisher Of

  • Real-Time Functional Magnetic Resonance Imaging 2018
  • HIV-1 subtype C is significantly more infectious than other subtypes.  Journal of the International Aids Society.  18. 2015
  • Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1.  Journal of the International Aids Society.  18. 2015
  • Home-based mental health services are associated with improved mental health outcomes among individuals with HIV.  Journal of the International Aids Society.  15:173-173. 2012
  • Methamphetamine use is associated with sexual abuse and HIV sexual risk behaviours among patrons of alcohol serving venues in Cape Town, South Africa.  Journal of the International Aids Society.  15:89-90. 2012
  • Economic evaluation of offshore storage potential in the US Exclusive Economic Zone.  Greenhouse Gases: Science and Technology.  n/a-n/a. 2012
  • DEVELOPMENT AND PRELIMINARY EVALUATION OF A 11C LABELED SULFONAMIDE DERIVATES AS POTENTIAL PET TRACER FOR BLOOD POOL IMAGING.  Journal of Labelled Compounds & Radiopharmaceuticals.  52:S341-S341. 2009
  • DOTA-SIB, A TRIFUNCTIONAL PROSTHETIC GROUP FOR MULTI-MODAL LABELING.  Journal of Labelled Compounds & Radiopharmaceuticals.  52:S70-S70. 2009
  • SYNTHESIS AND BIOLOGICAL EVALUATION OF A NEGATIVELY CHARGED 99mTc-LABELLED AMINOETHYLBENZENE SULFONAMIDE CONJUGATE FOR IN VIVO VISUALISATION OF CARBONIC ANHYDRASE IX (CA IX) EXPRESSION AS A SURROGATE MARKER OF TUMOR HYPOXIA.  Journal of Labelled Compounds & Radiopharmaceuticals.  52:S135-S135. 2009
  • Evaluating quantitative benefit-risk analysis for drug-approval decision making in Europe and the United States.  Pharmacoepidemiology and Drug Safety.  17:S26-S26. 2008
  • Stress levels and sources of stress in an adult brain tumor population.  Psycho Oncology.  16:S140-S141. 2007
  • The sexual function domain of the NIHPROMIS: Preliminary report.  Psycho Oncology.  16:S233-S233. 2007
  • Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis.  Pharmacoepidemiology and Drug Safety.  16:S183-S183. 2007
  • Patients willingness to accept risk-benefit trade-offs in treating Crohn's disease.  Pharmacoepidemiology and Drug Safety.  15:S138-S139. 2006
  • Willingness to accept risk-benefit tradeoffs: Pharmacoepidemiology meets preference measurement.  Pharmacoepidemiology and Drug Safety.  15:S36-S37. 2006
  • Association between the Parent Experience of Childhood Illness (PECI) scale and clinician ratings of functioning among parents of children with cancer.  Psycho Oncology.  15:S41-S42. 2006
  • Brain tumor patients: Stress and intervention preferences.  Psycho Oncology.  15:S77-S78. 2006
  • Caregivers of brain tumor patients: Stress and intervention preferences.  Psycho Oncology.  15:S52-S52. 2006
  • Telephone monitoring: Early identification of psychological, physical and social distress in older advanced-stage cancer patients.  Psycho Oncology.  15:S21-S22. 2006
  • Virtual reality intervention for chemotherapy symptoms.  Psycho Oncology.  15:S7-S7. 2006
  • Hsl1 as a sensor of cell shape..  Yeast (Chichester, England).  18:S142-S142. 2001
  • Heterologous URA3MX cassettes for gene replacement in Saccharomyces cerevisiae (vol 15, pg 507, 1999).  Yeast (Chichester, England).  15:1297-1297. 1999
  • SYMPOSIUM ON THE CHILDHOOD ENVIRONMENT AND ADULT DISEASE, HELD AT THE CIBA-FOUNDATION, LONDON, 15-17 MAY 1990 - GENERAL DISCUSSION.  Ciba Foundation Symposium.  156:224-234. 1991
  • AN ANALYSIS OF UNITED-STATES INTERNATIONAL COMPETITIVENESS IN PHARMACEUTICALS.  Managerial and Decision Economics.  27-33. 1989
  • DNA Brushes: Advances in Synthesis and Applications
  • Brain Stimulation in Psychiatry
  • Epigenetic inheritance and RNAi at the centromere and heterochromatin
  • Psychopharmacology and the Consequences of Alcohol and Drug Interactions
  • Poxviruses 2015
  • ASCENT: Phase 2a, randomized, double-blind, placebo controlled study evaluating safety and immunogenicity of two HIV-1 prophylactic vaccine regimens comprising Ad26. Mos4. HIV and either clade C gp140 or bivalent gp140.  Journal of the International Aids Society. 98-98. 2019
  • Protein-supplemented DNA/MVA vaccines: Preclinical immunogenicity and protection for transmitted/founder (B.63521 Delta 11mutC) and CD4-induced gp120 (rhFLSC) proteins.  Journal of the International Aids Society. 19-20. 2019
  • Social-media based secondary distribution of HIV self-testing among Chinese men who have sex with men: A pilot implementation programme assessment.  Journal of the International Aids Society. 56-56. 2019
  • "My best friends and my worst enemies:" understanding the roles of families in retaining South African adolescents living with HIV in care.  Journal of the International Aids Society. 58-58. 2018
  • A CD4-mimetic compound enhances vaccine efficacy against stringent immunodeficiency virus challenge.  Journal of the International Aids Society. 1-1. 2018
  • Long-term data from APPROACH: phase 1/2a randomized, double-blind, placebo-controlled study evaluating safety/tolerability and immunogenicity of vaccine regimens using combinations of Ad26.Mos.HIV, MVA-mosaic and gp140 envelope protein.  Journal of the International Aids Society. 2-3. 2018
  • Oral MVA/protein HIV vaccination with a needle-free injector induces robust systemic and mucosal antibody responses in rhesus macaques.  Journal of the International Aids Society. 2-2. 2018
  • Time to treatment initiation for drug-resistant tuberculosis is delayed in a South African prospective cohort.  Journal of the International Aids Society. 17-17. 2017
  • SOF/VEL single-tablet regimen in HCV mono-infected and HIV/HCV co-infected patients: comparison of efficacy and safety data from phase 3 clinical trials.  Journal of the International Aids Society. 2016
  • Deferred antiretroviral therapy is associated with lower estimated glomerular filtration rate in HIV-positive individuals with high CD4 counts.  Journal of the International Aids Society. 2016
  • Elimination of HIV-1 latently infected cells by PKC agonist gnidimacrin alone and in combination with a histone deacetylase inhibitor.  Journal of the International Aids Society. 2016
  • Meeting the "Go'' criteria: immunogenicity from HVTN100, a phase 1/2 randomized, double blind, placebo-controlled trial of clade C ALVAC-(R) (vCP2438) and Bivalent Subtype C gp120/MF59 (R) in HIV-uninfected South African adults.  Journal of the International Aids Society. 2016
  • Optimizing the frequency of kidney safety monitoring in HIV-uninfected persons using daily oral tenofovir disoproxil fumarate pre-exposure prophylaxis.  Journal of the International Aids Society. 2016
  • Sofosbuvir/velpatasvir fixed dose combination for 12 weeks in patients co-infected with HCV and HIV-1: the phase.  Journal of the International Aids Society. 2016
  • Streamlined quasispecies and subtype analysis of HIV-1 sequences generated by high-throughput sequencing using the high-performance integrated virtual environment (HIVE).  Journal of the International Aids Society. 2016
  • Treatment interruptions in HIV cure studies in the United States: perceptions, motivations and ethical considerations from potential HIV-positive volunteers.  Journal of the International Aids Society. 2016
  • HIV-1-specific IgG antibody levels correlate with the presence of a specific HLA class II allele to impact acquisition and vaccine efficacy.  Journal of the International Aids Society. 2015
  • Integration of global techniques to implicate post-transcriptional regulation in HIV infection.  Journal of the International Aids Society. 23-23. 2012
  • Conceptualizations of sexual functioning and intimacy among cancer sufferers and survivors.  Psycho Oncology. S135-S136. 2007
  • Decisional conflict among patients who accept or decline participation in phase I cancer clinical trials.  Psycho Oncology. S166-S167. 2007
  • Prevalence of symptoms, medical conditions post diagnosis, physical functioning and communication with doctors among adult non-Hodgkin lymphoma survivors.  Psycho Oncology. S54-S54. 2007
  • Follow-up care in cancer survivors: Newsletters cannot do it alone - A report from the childhood cancer survivor study.  Psycho Oncology. S25-S26. 2007
  • Steady ongoing hematological and immunological reconstitution achieved in ADA-deficiency patients treated by stem cell gene therapy with no myelopreparative conditioning.  The Journal of Gene Medicine. 1442-1442. 2006
  • Advocacy skills training for young adult cancer survivors: The Young Adult Survivors Conference (YASC) at Camp Make-a-Dream.  Psycho Oncology. S7-S8. 2006
  • A tumour specific targeted radiotherapy/gene therapy for the treatment of malignant disease.  The Journal of Gene Medicine. S33-S34. 2004
  • Enhancement of targeted radiotherapy in neuroblastoma: a novel gene therapy approach.  The Journal of Gene Medicine. S27-S27. 2004
  • Investigation of cell kill in a targeted radiotherapy/gene therapy strategy utilising radiation induced biological bystander effects.  The Journal of Gene Medicine. S30-S30. 2004
  • FROM COMBINATORIAL SYNTHESIS TO CELLULAR PROBES: DESIGNING CYCLIC AND MULTIVALENT PEPTIDE LIGANDS AS INHIBITORS OF SIGNAL TRANSDUCTION PROTEINS.  Journal of Peptide Science : an Official Publication of the European Peptide Society. 115-115. 2004
  • A new class of heterotrimeric G protein governs yeast pseudohyphal differentiation..  Yeast (Chichester, England). S77-S77. 2003
  • Cyclophilin A is nuclear localized and controls the sporulation gene program of Saccharomyces cerevisiae..  Yeast (Chichester, England). S171-S171. 2003
  • Saccharomyces cerevisiae as a model of human fungal pathogens..  Yeast (Chichester, England). S17-S17. 2003
  • The role of F-actin in Cdc42p polarization..  Yeast (Chichester, England). S67-S67. 2003
  • Major liver resection in the elderly.  British Journal of Surgery. 62-62. 2002
  • 'No touch' radical regional resection for hilar cholangiocarcinoma: technique and outcome.  British Journal of Surgery. 379-379. 2002
  • Fungal survival factors: analysis of in vivo carbon source utilization using clinically derived strains of Saccharomyces cerevisiae in a mouse model of systemic infection..  Yeast (Chichester, England). S309-S309. 2001
  • Limitations on predictive modeling in geomorphology.  Scientific Nature of Geomorphology. 337-358. 1996
  • Advanced glycosylation end-products contribute to amyloidosis in Alzheimer's disease.  597-605. 1995
  • Apolipoprotein E and the epidemiology of Alzheimer's disease.  53-62. 1995
  • STABILITY MEASUREMENTS IN NONLINEAR MECHANICAL EXPERIMENTS GUIDED BY DYNAMICAL SYSTEMS THEORY.  59-70. 1994
  • SYMPOSIUM ON THE CHILDHOOD ENVIRONMENT AND ADULT DISEASE, HELD AT THE CIBA-FOUNDATION, LONDON, 15-17 MAY 1990 - GENERAL DISCUSSION.  224-234. 1991